503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
36.07%
Net income growth at 75-90% of ZETA's 40.68%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
-30.51%
Both reduce yoy D&A, with ZETA at -1.61%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-99.12%
Negative yoy deferred tax while ZETA stands at 53.19%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-37.18%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.18%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
680.25%
Some yoy increase while ZETA is negative at -192.80%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
27.33%
Operating cash flow growth 1.25-1.5x ZETA's 20.83%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
38.83%
CapEx growth well above ZETA's 14.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
97.67%
Some acquisitions while ZETA is negative at -26.79%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-33.51%
Negative yoy purchasing while ZETA stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
11.94%
Liquidation growth of 11.94% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-4064.44%
Both yoy lines negative, with ZETA at -18.84%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-4.92%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
13.92%
We have some buyback growth while ZETA is negative at -23.83%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.